Home > National Drug Code (NDC) > Atovaquone and Proguanil Hydrochloride

Atovaquone and Proguanil Hydrochloride - 43063-393-20 - (Atovaquone and Proguanil Hydrochloride)

Alphabetical Index


Drug Information of Atovaquone and Proguanil Hydrochloride

Product NDC: 43063-393
Proprietary Name: Atovaquone and Proguanil Hydrochloride
Non Proprietary Name: Atovaquone and Proguanil Hydrochloride
Active Ingredient(s): 250; 100    mg/1; mg/1 & nbsp;   Atovaquone and Proguanil Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Atovaquone and Proguanil Hydrochloride

Product NDC: 43063-393
Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA091211
Marketing Category: ANDA
Start Marketing Date: 20110818

Package Information of Atovaquone and Proguanil Hydrochloride

Package NDC: 43063-393-20
Package Description: 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-393-20)

NDC Information of Atovaquone and Proguanil Hydrochloride

NDC Code 43063-393-20
Proprietary Name Atovaquone and Proguanil Hydrochloride
Package Description 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-393-20)
Product NDC 43063-393
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Atovaquone and Proguanil Hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110818
Marketing Category Name ANDA
Labeler Name PD-Rx Pharmaceuticals, Inc.
Substance Name ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Strength Number 250; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]

Complete Information of Atovaquone and Proguanil Hydrochloride


General Information